147 related articles for article (PubMed ID: 37682815)
21. Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors.
Mann JP; Carter P; Armstrong MJ; Abdelaziz HK; Uppal H; Patel B; Chandran S; More R; Newsome PN; Potluri R
PLoS One; 2020; 15(10):e0241357. PubMed ID: 33108366
[TBL] [Abstract][Full Text] [Related]
22. Dietary magnesium and risk of cardiovascular and all-cause mortality after myocardial infarction: A prospective analysis in the Alpha Omega Cohort.
Evers I; Cruijsen E; Kornaat I; Winkels RM; Busstra MC; Geleijnse JM
Front Cardiovasc Med; 2022; 9():936772. PubMed ID: 36035961
[TBL] [Abstract][Full Text] [Related]
23. Coffee consumption is not associated with prevalent subclinical cardiovascular disease (CVD) or the risk of CVD events, in nonalcoholic fatty liver disease: results from the multi-ethnic study of atherosclerosis.
Simon TG; Trejo MEP; Zeb I; Frazier-Wood AC; McClelland RL; Chung RT; Budoff MJ
Metabolism; 2017 Oct; 75():1-5. PubMed ID: 28964324
[TBL] [Abstract][Full Text] [Related]
24. Role of fatty liver index in risk-stratifying comorbid disease outcomes in non-alcoholic fatty liver disease.
Ho B; Thompson A; Jorgensen AL; Pirmohamed M
JHEP Rep; 2023 Dec; 5(12):100896. PubMed ID: 37928746
[TBL] [Abstract][Full Text] [Related]
25. Oxidative stress is associated with suspected non-alcoholic fatty liver disease and all-cause mortality in the general population.
Damba T; Bourgonje AR; Abdulle AE; Pasch A; Sydor S; van den Berg EH; Gansevoort RT; Bakker SJL; Blokzijl H; Dullaart RPF; van Goor H; Moshage H
Liver Int; 2020 Sep; 40(9):2148-2159. PubMed ID: 32558346
[TBL] [Abstract][Full Text] [Related]
26. Prescription of statins in suspected non-alcoholic fatty liver disease and high cardiovascular risk, a population-based study.
van den Berg EH; Wolters AAB; Dullaart RPF; Moshage H; Zurakowski D; de Meijer VE; Blokzijl H
Liver Int; 2019 Jul; 39(7):1343-1354. PubMed ID: 30968536
[TBL] [Abstract][Full Text] [Related]
27. Non-Alcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: Role of Circulating Branched-Chain Amino Acids.
van den Berg EH; Flores-Guerrero JL; Gruppen EG; de Borst MH; Wolak-Dinsmore J; Connelly MA; Bakker SJL; Dullaart RPF
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30917546
[TBL] [Abstract][Full Text] [Related]
28. Fatty liver index and cardiovascular outcomes in never-treated hypertensive patients: a prospective cohort.
Siafi E; Andrikou I; Thomopoulos C; Konstantinidis D; Kakouri N; Tatakis F; Kariori M; Filippou C; Zamanis I; Manta E; Drogkaris S; Liatakis I; Polyzos D; Tsioufis C
Hypertens Res; 2023 Jan; 46(1):119-127. PubMed ID: 36229524
[TBL] [Abstract][Full Text] [Related]
29. Serum Level of Cytokeratin 18 (M65) as a Prognostic Marker of High Cardiovascular Disease Risk in Individuals with Non-Alcoholic Fatty Liver Disease.
Pagano S; Bakker SJL; Juillard C; Dullaart RPF; Vuilleumier N
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509164
[TBL] [Abstract][Full Text] [Related]
30. Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease.
Arvind A; Henson JB; Osganian SA; Nath C; Steinhagen LM; Memel ZN; Donovan A; Balogun O; Chung RT; Simon TG; Corey KE
Hepatol Commun; 2022 Feb; 6(2):309-319. PubMed ID: 34558862
[TBL] [Abstract][Full Text] [Related]
31. Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Otgonsuren M; Estep MJ; Hossain N; Younossi E; Frost S; Henry L; Hunt S; Fang Y; Goodman Z; Younossi ZM
J Gastroenterol Hepatol; 2014 Dec; 29(12):2006-13. PubMed ID: 25039333
[TBL] [Abstract][Full Text] [Related]
32. Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality.
Ng CH; Wong ZY; Chew NWS; Chan KE; Xiao J; Sayed N; Lim WH; Tan DJH; Loke RWK; Tay PWL; Yong JN; Kong G; Huang DQ; Wang JW; Chan M; Dalakoti M; Tamaki N; Noureddin M; Siddiqui MS; Sanyal AJ; Muthiah M
Front Cardiovasc Med; 2022; 9():942753. PubMed ID: 36003916
[TBL] [Abstract][Full Text] [Related]
33. Fatty liver index (FLI) and prediction of new cases of non-alcoholic fatty liver disease: A population-based study of northern Iran.
Motamed N; Faraji AH; Khonsari MR; Maadi M; Tameshkel FS; Keyvani H; Ajdarkosh H; Karbalaie Niya MH; Rezaie N; Zamani F
Clin Nutr; 2020 Feb; 39(2):468-474. PubMed ID: 30922791
[TBL] [Abstract][Full Text] [Related]
34. Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease.
Moon JH; Kim W; Koo BK; Cho NH;
Gut Liver; 2022 May; 16(3):433-442. PubMed ID: 34635626
[TBL] [Abstract][Full Text] [Related]
35. The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease.
Ng CH; Chan KE; Chin YH; Zeng RW; Tsai PC; Lim WH; Tan DJH; Khoo CM; Goh LH; Ling ZJ; Kulkarni A; Mak LL; Huang DQ; Chan M; Chew NW; Siddiqui MS; Sanyal AJ; Muthiah M
Clin Mol Hepatol; 2022 Jul; 28(3):565-574. PubMed ID: 35585687
[TBL] [Abstract][Full Text] [Related]
36. Combined Effects of Chronic Kidney Disease and Nonalcoholic Fatty Liver Disease on the Risk of Cardiovascular Disease in Patients with Diabetes.
Chung GE; Han K; Lee KN; Cho EJ; Bae JH; Yang SY; Yu SJ; Choi SH; Yim JY; Heo NJ
Biomedicines; 2022 May; 10(6):. PubMed ID: 35740267
[TBL] [Abstract][Full Text] [Related]
37. Nonalcoholic fatty liver disease, circulating ketone bodies and all-cause mortality in a general population-based cohort.
Post A; Garcia E; van den Berg EH; Flores-Guerrero JL; Gruppen EG; Groothof D; Westenbrink BD; Connelly MA; Bakker SJL; Dullaart RPF
Eur J Clin Invest; 2021 Dec; 51(12):e13627. PubMed ID: 34120339
[TBL] [Abstract][Full Text] [Related]
38. Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease.
Chinnadurai R; Chrysochou C; Kalra PA
Nephron; 2019; 141(1):24-30. PubMed ID: 30384370
[TBL] [Abstract][Full Text] [Related]
39. Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study.
Morlán-Coarasa MJ; Arias-Loste MT; Ortiz-García de la Foz V; Martínez-García O; Alonso-Martín C; Crespo J; Romero-Gómez M; Fábrega E; Crespo-Facorro B
Psychopharmacology (Berl); 2016 Dec; 233(23-24):3947-3952. PubMed ID: 27620899
[TBL] [Abstract][Full Text] [Related]
40. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
